EHMTI-0283. Predictors of early response to onabotulinumtoxin type a in chronic migraine

被引：0
|
作者：
N Mas-Sala
M Quintana
J Alvarez-Sabin
P Pozo-Rosich
机构：
[1] Hospital Universitari Vall d'Hebron,Neurology
来源：
The Journal of Headache and Pain | 2014年 / 15卷
关键词：
Migraine; Early Response; Chronic Migraine; Headache Frequency; Episodic Migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Predictors of response to galcanezumab in patients with chronic migraine; real world data
    Lee, Hyoung Cheol
    Cho, Soohyun
    Kim, Byung-Kun
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 2 - 2
  • [32] Pharmacologically-controlled withdrawal from medication overuse in chronic migraine does not improve the therapeutic response to long-term onabotulinumtoxin type-a prophylaxis
    Rebecchi, Valentina
    Cariddi, Lucia Princiotta
    Clerici, Angelo Maurizio
    Carimati, Federico
    Gallazzi, Marco
    Mauri, Marco
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [33] OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
    Dominguez, C.
    Pozo-Rosich, P.
    Torres-Ferrus, M.
    Hernandez-Beltran, N.
    Jurado-Cobo, C.
    Gonzalez-Oria, C.
    Santos, S.
    Monzon, M. J.
    Latorre, G.
    Alvaro, L. C.
    Gago, A.
    Gallego, M.
    Medrano, V.
    Huerta, M.
    Garcia-Alhama, J.
    Belvis, R.
    Leira, Y.
    Leira, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (02) : 411 - 416
  • [34] Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine
    Ceccardi, Giulia
    di Cola, Francesca Schiano
    Caratozzolo, Salvatore
    Di Pasquale, Michele
    Bolchini, Marco
    Padovani, Alessandro
    Rao, Renata
    TOXINS, 2023, 15 (12)
  • [35] Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
    Dawn C. Buse
    Paul K. Winner
    Larry Charleston
    Joe Hirman
    Roger Cady
    Thomas Brevig
    The Journal of Headache and Pain, 2022, 23
  • [36] Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
    Buse, Dawn C.
    Winner, Paul K.
    Charleston, Larry
    Hirman, Joe
    Cady, Roger
    Brevig, Thomas
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [37] Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center
    Ornello, Raffaele
    Lisi, Serena Vittoria
    Degan, Diana
    Tiseo, Cindy
    Pistoia, Francesca
    Carolei, Antonio
    Sacco, Simona
    JOURNAL OF HEADACHE AND PAIN, 2015, 16 : 1 - 2
  • [38] Early predictors of response to treatment in patients with chronic hepatitis C
    Civeira, MP
    Prieto, J
    JOURNAL OF HEPATOLOGY, 1999, 31 : 237 - 243
  • [39] EHMTI-0354. Abnormal expression of gene transcripts linked to inflammatory response in the periosteum of chronic migraine patients: implications to extracranial origin of headache
    R Burstein
    C Perry
    P Blake
    C Buettner
    M Bhasin
    The Journal of Headache and Pain, 2014, 15
  • [40] Early response to eptinezumab indicates high likelihood of continued response with treatment in patients with chronic migraine
    Buse, D. C.
    Winner, P. K.
    Charleston, L.
    Hirman, J.
    Cady, R.
    Brevig, T.
    HEADACHE, 2021, 61 : 121 - 121
12345